Global Gene Synthesis Market - Industry Trends Forecast to 2029

Description

List of Tables

Global Gene Synthesis Market is projected to register a substantial CAGR of 22.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation:

Global Gene Synthesis Market, By Component ( Synthesizer, Consumables, and Software & Services), Gene Type (Standard Gene, Express Gene, Complex Gene, and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutic Antibodies, and Others), Method (Solid Phase Synthesis, CHIP Based DNA Synthesis, and PCR Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostic Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distribution), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Switzerland, Netherlands, Belgium, Ireland, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Australia, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, and Rest of Middle East and Africa) Industry Trends & Forecast to 2029.

Some of the major factors contributing to the growth of the global gene synthesis market are:

Increased prevalence of chronic infectious diseases
Expansion of synthetic biology
Rising interest in gene synthesis in the field of molecular biology
Rising adoption of gene therapy

Market Players:

Some of the key market players in the Global gene synthesis market are listed below:

Twist Bioscience
Thermo Fisher Scientific Inc.
GenScript
Merck KGaA
Integrated DNA Technologies, Inc.
Bio Basic Inc.
trenzyme GmbH
Others

1 INTRODUCTION 40

1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF GLOBAL GENE SYNTHESIS MARKET 40
1.4 CURRENCY AND PRICING 42
1.5 LIMITATION 42
1.6 MARKETS COVERED 43

2 MARKET SEGMENTATION 45

2.1 MARKETS COVERED 45
2.2 GEOGRAPHIC SCOPE 46
2.3 YEARS CONSIDERED FOR THE STUDY 47
2.4 CURRENCY AND PRICING 47
2.5 RESEARCH METHODOLOGY 48
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.7 MULTIVARIATE MODELLING 52
2.8 COMPONENT SEGMENT LIFELINE CURVE 52
2.9 DBMR MARKET POSITION GRID 53
2.10 VENDOR SHARE ANALYSIS 55
2.11 MARKET APPLICATION COVERAGE GRID 56
2.12 THE CATEGORY VS TIME GRID 57
2.13 SECONDARY SOURCES 58
2.14 ASSUMPTIONS 58

3 EXECUTIVE SUMMARY 59

4 PREMIUM INSIGHTS 62

4.1 PESTEL 65
4.2 PORTER'S FIVE FORCES MODEL 66

5 GLOBAL GENE SYNTHESIS MARKET: REGULATIONS 67

6 MARKET OVERVIEW 71

6.1 DRIVERS 73
- 6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES 73
- 6.1.2 RISING ADOPTION OF GENE THERAPY 73
- 6.1.3 EXPANSION OF SYNTHETIC BIOLOGY 74
- 6.1.4 RISING INTEREST OF GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY 74
6.2 RESTRAINTS 75
- 6.2.1 LACK OF TRAINED PROFESSIONALS 75
- 6.2.2 ETHICAL ISSUES 75
- 6.2.3 LONG APPROVAL PROCESS 75
6.3 OPPORTUNITIES 76
- 6.3.1 RISE IN HEALTHCARE EXPENDITURE 76
- 6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 76
- 6.3.3 RISING DEMAND FOR CUSTOMIZED MEDICATIONS 77
6.4 CHALLENGES 77
- 6.4.1 TECHNICAL LIMITATIONS ACROSS PRODUCTION PROCESS 77
- 6.4.2 LACK OF WELL DEFINED PATENT SYSTEM 78

7 GLOBAL GENE SYNTHESIS MARKET, BY COMPONENT 79

7.1 OVERVIEW 80
7.2 SOFTWARE & SERVICES 83
7.3 CONSUMABLES 83
- 7.3.1 REAGENTS 84
- 7.3.2 ASSAYS 84
- 7.3.3 PROBES & DYES 84
- 7.3.4 OTHERS 84
7.4 SYNTHESIZER 84
- 7.4.1 COLUMN-BASED SYNTHESIZERS 85
- 7.4.2 MICROARRAY-BASED SYNTHESIZERS 85

8 GLOBAL GENE SYNTHESIS MARKET, BY GENE TYPE 86

8.1 OVERVIEW 87
8.2 STANDARD GENE 90
8.3 COMPLEX GENE 90
8.4 EXPRESS GENE 91
8.5 OTHERS 91

9 GLOBAL GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE 92

9.1 OVERVIEW 93
9.2 CUSTOM GENE SYNTHESIS 96
- 9.2.1 STANDARD GENE 96
- 9.2.2 COMPLEX GENE 96
- 9.2.3 EXPRESS GENE 96
- 9.2.4 OTHERS 97
9.3 GENE LIBRARY SYNTHESIS 97
- 9.3.1 STANDARD GENE 97
- 9.3.2 COMPLEX GENE 97
- 9.3.3 EXPRESS GENE 98
- 9.3.4 OTHERS 98

10 GLOBAL GENE SYNTHESIS MARKET, BY APPLICATION 99

10.1 OVERVIEW 100
10.2 SYNTHETIC BIOLOGY 103
- 10.2.1 CUSTOM GENE SYNTHESIS 103
- 10.2.2 GENE LIBRARY SYNTHESIS 103
10.3 GENETIC ENGINEERING 104
- 10.3.1 CUSTOM GENE SYNTHESIS 104
- 10.3.2 GENE LIBRARY SYNTHESIS 104
10.4 THERAPEUTIC ANTIBODIES 104
- 10.4.1 CUSTOM GENE SYNTHESIS 105
- 10.4.2 GENE LIBRARY SYNTHESIS 105
10.5 VACCINE DESIGN 105
- 10.5.1 CUSTOM GENE SYNTHESIS 106
- 10.5.2 GENE LIBRARY SYNTHESIS 106
10.6 OTHERS 107

11 GLOBAL GENE SYNTHESIS MARKET, BY METHOD 108

11.1 OVERVIEW 109
11.2 PCR-BASED ENZYME SYNTHESIS 112
11.3 CHIP-BASED DNA SYNTHESIS 112
11.4 SOLID BASED SYNTHESIS 112

12 GLOBAL GENE SYNTHESIS MARKET, BY END USER 114

12.1 OVERVIEW 115
12.2 ACADEMIC & RESEARCH INSTITUTE 118
12.3 BIOTECH & PHARMACEUTICAL COMPANIES 118
12.4 DIAGNOSTIC LABORATORIES 118
12.5 OTHERS 119

13 GLOBAL GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL 120

13.1 OVERVIEW 121
13.2 DIRECT TENDER 124
13.3 ONLINE DISTRIBUTION 124
13.4 THIRD PARTY DISTRIBUTORS 124

14 GLOBAL GENE SYNTHESIS MARKET, BY REGION 126

14.1 OVERVIEW 127
14.2 NORTH AMERICA 133
- 14.2.1 U.S. 143
- 14.2.2 CANADA 147
- 14.2.3 MEXICO 151
14.3 EUROPE 155
- 14.3.1 GERMANY 165
- 14.3.2 U.K. 169
- 14.3.3 ITALY 173
- 14.3.4 SPAIN 177
- 14.3.5 FRANCE 181
- 14.3.6 NETHERLANDS 185
- 14.3.7 RUSSIA 189
- 14.3.8 SWITZERLAND 193
- 14.3.9 TURKEY 197
- 14.3.10 BELGIUM 201
- 14.3.11 REST OF EUROPE 205
14.4 ASIA-PACIFIC 206
- 14.4.1 CHINA 217
- 14.4.2 JAPAN 221
- 14.4.3 INDIA 225
- 14.4.4 SOUTH KOREA 229
- 14.4.5 AUSTRALIA 233
- 14.4.6 SINGAPORE 237
- 14.4.7 MALAYSIA 241
- 14.4.8 THAILAND 245
- 14.4.9 INDONESIA 249
- 14.4.10 PHILIPPINES 253
- 14.4.11 REST OF ASIA-PACIFIC 257
14.5 SOUTH AMERICA 258
- 14.5.1 BRAZIL 268
- 14.5.2 ARGENTINA 272
- 14.5.3 REST OF SOUTH AMERICA 276
14.6 MIDDLE EAST &AFRICA 277
- 14.6.1 SAUDI ARABIA 287
- 14.6.2 SOUTH AFRICA 291
- 14.6.3 U.A.E. 295
- 14.6.4 ISRAEL 299
- 14.6.5 EGYPT 303
- 14.6.6 REST OF MIDDLE EAST & AFRICA 307

15 GLOBAL GENE SYNTHESIS MARKET: COMPANY LANDSCAPE 308

15.1 COMPANY SHARE ANALYSIS: GLOBAL 308
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 309
15.3 COMPANY SHARE ANALYSIS: EUROPE 310
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 311

16 SWOT ANALYSIS 312

17 COMPANY PROFILE 313

17.1 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER) 313
- 17.1.1 COMPANY SNAPSHOT 313
- 17.1.2 COMPANY SHARE ANALYSIS 313
- 17.1.3 PRODUCT PORTFOLIO 314
- 17.1.4 RECENT DEVELOPMENTS 314
17.2 THERMO FISHER SCIENTIFIC INC. 315
- 17.2.1 COMPANY SNAPSHOT 315
- 17.2.2 REVENUE ANALYSIS 315
- 17.2.3 COMPANY SHARE ANALYSIS 316
- 17.2.4 PRODUCT PORTFOLIO 316
- 17.2.5 RECENT DEVELOPMENT 317
17.3 EUROFINS SCIENTIFIC 318
- 17.3.1 COMPANY SNAPSHOT 318
- 17.3.2 REVENUE ANALYSIS 318
- 17.3.3 COMPANY SHARE ANALYSIS 319
- 17.3.4 SERVICE PORTFOLIO 319
- 17.3.5 RECENT DEVELOPMENT 320
17.4 MERCK KGAA 321
- 17.4.1 COMPANY SNAPSHOT 321
- 17.4.2 REVENUE ANALYSIS 321
- 17.4.3 COMPANY SHARE ANALYSIS 322
- 17.4.4 PRODUCT PORTFOLIO 322
- 17.4.5 RECENT DEVELOPMENT 323
17.5 KANEKA EUROGENTEC S.A. 324
- 17.5.1 COMPANY SNAPSHOT 324
- 17.5.2 REVENUE ANALYSIS 324
- 17.5.3 COMPANY SHARE ANALYSIS 325
- 17.5.4 PRODUCT PORTFOLIO 325
- 17.5.5 RECENT DEVELOPMENTS 326
17.6 ANSA BIOTECHNOLOGIES, INC 327
- 17.6.1 COMPANY SNAPSHOT 327
- 17.6.2 PRODUCT PORTFOLIO 327
- 17.6.3 RECENT DEVELOPMENTS 327
17.7 ATD BIO LTD 328
- 17.7.1 COMPANY SNAPSHOT 328
- 17.7.2 REVENUE ANALYSIS 328
- 17.7.3 PRODUCT PORTFOLIO 329
- 17.7.4 RECENT DEVELOPMENTS 329
17.8 ATG:BIOSYNTHETICS GMBH 330
- 17.8.1 COMPANY SNAPSHOT 330
- 17.8.2 PRODUCT PORTFOLIO 330
- 17.8.3 RECENT DEVELOPMENTS 330
17.9 AZENTUS US, INC (2021) 331
- 17.9.1 COMPANY SNAPSHOT 331
- 17.9.2 REVENUE ANALYSIS 331
- 17.9.3 PRODUCT PORTFOLIO 332
- 17.9.4 RECENT DEVELOPMENT 332
17.10 BBI LIFESCIENCES CORPORATION 333
- 17.10.1 COMPANY SNAPSHOT 333
- 17.10.2 PRODUCT PORTFOLIO 333
- 17.10.3 RECENT DEVELOPMENTS 333
17.11 BIO BASIC INC. 334
- 17.11.1 COMPANY SNAPSHOT 334
- 17.11.2 PRODUCT PORTFOLIO 334
- 17.11.3 RECENT DEVELOPMENTS 334
17.12 BIOCAT GMBH 335
- 17.12.1 COMPANY SNAPSHOT 335
- 17.12.2 PRODUCT PORTFOLIO 335
- 17.12.3 RECENT DEVELOPMENTS 335
17.13 BIONEER PACIFIC 336
- 17.13.1 COMPANY SNAPSHOT 336
- 17.13.2 PRODUCT PORTFOLIO 336
- 17.13.3 RECENT DEVELOPMENT 336
17.14 BOSTER BIOLOGICAL TECHNOLOGY 337
- 17.14.1 COMPANY SNAPSHOT 337
- 17.14.2 SERVICE PORTFOLIO 337
- 17.14.3 RECENT DEVELOPMENT 337
17.15 CSBIO 338
- 17.15.1 COMPANY SNAPSHOT 338
- 17.15.2 PRODUCT PORTFOLIO 338
- 17.15.3 RECENT DEVELOPMENTS 338
17.16 CREATIVE BIOGENE 339
- 17.16.1 COMPANY SNAPSHOT 339
- 17.16.2 RODUCTPORTFOLIO 339
- 17.16.3 RECENT DEVELOPMENT 339
17.17 EVONETIX 340
- 17.17.1 COMPANY SNAPSHOT 340
- 17.17.2 PRODUCT PORTFOLIO 340
- 17.17.3 RECENT DEVELOPMENTS 341
17.18 EXONBIO 342
- 17.18.1 COMPANY SNAPSHOT 342
- 17.18.2 PRODUCT PORTFOLIO 342
- 17.18.3 RECENT DEVELOPMENT 342
17.19 GCC BIOTECH (INDIA) PVT. LTD. 343
- 17.19.1 COMPANY SNAPSHOT 343
- 17.19.2 PRODUCT PORTFOLIO 343
- 17.19.3 RECENT DEVELOPMENT 343
17.20 GINKGO BIOWORKS (2021) 344
- 17.20.1 COMPANY SNAPSHOT 344
- 17.20.2 REVENUE ANALYSIS 344
- 17.20.3 PRODUCT PORTFOLIO 345
- 17.20.4 RECENT DEVELOPMENTS 345
17.21 GENERAL BIOSYSTEMS INC 346
- 17.21.1 COMPANY SNAPSHOT 346
- 17.21.2 PRODUCT PORTFOLIO 346
- 17.21.3 RECENT DEVELOPMENTS 346
17.22 GENSCRIPT 347
- 17.22.1 COMPANY SNAPSHOT 347
- 17.22.2 REVENUE ANALYSIS 347
- 17.22.3 PRODUCT PORTFOLIO 348
- 17.22.4 RECENT DEVELOPMENTS 348
17.23 MACROGEN CO., LTD. (A SUBSIDIARY OF MACROGEN, INC) 349
- 17.23.1 COMPANY SNAPSHOT 349
- 17.23.2 REVENUE ANALYSIS 349
- 17.23.3 PRODUCT PORTFOLIO 350
- 17.23.4 RECENT DEVELOPMENTS 350
17.24 NZYTECH, LDA. - GENES AND ENZYMES. 351
- 17.24.1 COMPANY SNAPSHOT 351
- 17.24.2 PRODUCT PORTFOLIO 351
- 17.24.3 RECENT DEVELOPMENT 351
17.25 ORIGENE TECHNOLOGIES, INC 352
- 17.25.1 COMPANY SNAPSHOT 352
- 17.25.2 PRODUCT PORTFOLIO 352
- 17.25.3 RECENT DEVELOPMENTS 352
17.26 PROMAB BIOTECHNOLOGIES 353
- 17.26.1 COMPANY SNAPSHOT 353
- 17.26.2 PRODUCT PORTFOLIO 353
- 17.26.3 RECENT DEVELOPMENTS 353
17.27 PROTEOGENIX 354
- 17.27.1 COMPANY SNAPSHOT 354
- 17.27.2 PRODUCT PORTFOLIO 354
- 17.27.3 RECENT DEVELOPMENTS 354
17.28 SYNBIO TECHNOLOGIES 355
- 17.28.1 COMPANY SNAPSHOT 355
- 17.28.2 PRODUCT PORTFOLIO 355
- 17.28.3 RECENT DEVELOPMENTS 356
17.29 TRENZYME GMBH 357
- 17.29.1 COMPANY SNAPSHOT 357
- 17.29.2 PRODUCT PORTFOLIO 357
- 17.29.3 RECENT DEVELOPMENTS 357
17.30 TWIST BIOSCIENCE 358
- 17.30.1 COMPANY SNAPSHOT 358
- 17.30.2 REVENUE ANALYSIS 358
- 17.30.3 PRODUCT PORTFOLIO 359
- 17.30.4 RECENT DEVELOPMENTS 359

18 QUESTIONNAIRE 360

19 RELATED REPORTS 363

LIST OF FIGURES

FIGURE 1 GLOBAL GENE SYNTHESIS MARKET: SEGMENTATION 45
FIGURE 2 GLOBAL GENE SYNTHESIS MARKET: GEOGRAPHIC SCOPE 46
FIGURE 3 GLOBAL GENE SYNTHESIS MARKET: DATA TRIANGULATION 48
FIGURE 4 GLOBAL GENE SYNTHESIS MARKET: SNAPSHOT 49
FIGURE 5 GLOBAL GENE SYNTHESIS MARKET: BOTTOM UP APPROACH 50
FIGURE 6 GLOBAL GENE SYNTHESIS MARKET: TOP DOWN APPROACH 50
FIGURE 7 GLOBAL GENE SYNTHESIS MARKET: INTERVIEWS BY REGION AND DESIGNATION 51
FIGURE 8 GLOBAL GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID 53
FIGURE 9 GLOBAL GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS 55
FIGURE 10 GLOBAL GENE SYNTHESIS MARKET: END USER COVERAGE GRID 56
FIGURE 11 GLOBAL GENE SYNTHESIS MARKET: THE CATEGORY VS TIME GRID 57
FIGURE 12 GLOBAL GENE SYNTHESIS MARKET SEGMENTATION 61
FIGURE 13 GROWING PREVALENCE OF CHRONIC INFECTIOUS DISEASES , EXPANSION OF SYNTHETIC BIOLOGY AND RISING ADOPTION OF GENE THERAPY ARE EXPECTED TO DRIVE THE MARKET FOR GLOBAL GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 62
FIGURE 14 SYNTHESIZER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL GENE SYNTHESIS MARKET IN 2022 & 2029 62
FIGURE 15 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GENE SYNTHESIS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2022 TO 2029 63
FIGURE 16 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GENE SYNTHESIS MARKET IN THE FORECAST PERIOD FROM 2022 TO 2029 64
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL GENE SYNTHESIS MARKET 72
FIGURE 18 GLOBAL GENE SYNTHESIS MARKET: BY COMPONENT, 2021 80
FIGURE 19 GLOBAL GENE SYNTHESIS MARKET: BY COMPONENT, 2022-2029 (USD MILLION) 81
FIGURE 20 GLOBAL GENE SYNTHESIS MARKET: BY COMPONENT, CAGR (2022-2029) 81
FIGURE 21 GLOBAL GENE SYNTHESIS MARKET: BY COMPONENT, LIFELINE CURVE 82
FIGURE 22 GLOBAL GENE SYNTHESIS MARKET: BY GENE TYPE, 2021 87
FIGURE 23 GLOBAL GENE SYNTHESIS MARKET: BY GENE TYPE, 2022-2029 (USD MILLION) 88
FIGURE 24 GLOBAL GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2022-2029) 88
FIGURE 25 GLOBAL GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE 89
FIGURE 26 GLOBAL GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2021 93
FIGURE 27 GLOBAL GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2022-2029 (USD MILLION) 94
FIGURE 28 GLOBAL GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, CAGR (2022-2029) 94
FIGURE 29 GLOBAL GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, LIFELINE CURVE 95
FIGURE 30 GLOBAL GENE SYNTHESIS MARKET: BY APPLICATION, 2021 100
FIGURE 31 GLOBAL GENE SYNTHESIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 101
FIGURE 32 GLOBAL GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2022-2029) 101
FIGURE 33 GLOBAL GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE 102
FIGURE 34 GLOBAL GENE SYNTHESIS MARKET: BY METHOD, 2021 109
FIGURE 35 GLOBAL GENE SYNTHESIS MARKET: BY METHOD, 2022-2029 (USD MILLION) 110
FIGURE 36 GLOBAL GENE SYNTHESIS MARKET: BY METHOD, CAGR (2022-2029) 110
FIGURE 37 GLOBAL GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE 111
FIGURE 38 GLOBAL GENE SYNTHESIS MARKET: BY END USER, 2021 115
FIGURE 39 GLOBAL GENE SYNTHESIS MARKET: BY END USER, 2021-2029 (USD MILLION) 116
FIGURE 40 GLOBAL GENE SYNTHESIS MARKET: BY END USER, CAGR (2022-2029) 116
FIGURE 41 GLOBAL GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE 117
FIGURE 42 GLOBAL GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2021 121
FIGURE 43 GLOBAL GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 122
FIGURE 44 GLOBAL GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 122
FIGURE 45 GLOBAL GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 123
FIGURE 46 GLOBAL GENE SYNTHESIS MARKET: SNAPSHOT (2021) 128
FIGURE 47 GLOBAL GENE SYNTHESIS MARKET: BY REGION (2021) 130
FIGURE 48 GLOBAL GENE SYNTHESIS MARKET: BY REGION (2022 & 2029) 130
FIGURE 49 GLOBAL GENE SYNTHESIS MARKET: BY REGION (2021 & 2029) 131
FIGURE 50 GLOBAL GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029) 131
FIGURE 51 NORTH AMERICA GENE SYNTHESIS MARKET: SNAPSHOT (2021) 134
FIGURE 52 NORTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2021) 136
FIGURE 53 NORTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029) 136
FIGURE 54 NORTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029) 137
FIGURE 55 NORTH AMERICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029) 137
FIGURE 56 EUROPE GENE SYNTHESIS MARKET: SNAPSHOT (2021) 156
FIGURE 57 EUROPE GENE SYNTHESIS MARKET: BY COUNTRY (2021) 158
FIGURE 58 EUROPE GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029) 158
FIGURE 59 EUROPE GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029) 159
FIGURE 60 EUROPE GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029) 159
FIGURE 61 ASIA-PACIFIC GENE SYNTHESIS MARKET: SNAPSHOT (2021) 207
FIGURE 62 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COUNTRY (2021) 209
FIGURE 63 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029) 209
FIGURE 64 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029) 210
FIGURE 65 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029) 211
FIGURE 66 SOUTH AMERICA GENE SYNTHESIS MARKET: SNAPSHOT (2021) 259
FIGURE 67 SOUTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2021) 261
FIGURE 68 SOUTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029) 261
FIGURE 69 SOUTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029) 262
FIGURE 70 SOUTH AMERICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029) 262
FIGURE 71 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT (2021) 278
FIGURE 72 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021) 280
FIGURE 73 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029) 280
FIGURE 74 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029) 281
FIGURE 75 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029) 281
FIGURE 76 GLOBAL GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%) 308
FIGURE 77 NORTH AMERICA GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%) 309
FIGURE 78 EUROPE GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%) 310
FIGURE 79 ASIA-PACIFIC GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%) 311